Baxter reported third-quarter 2026 sales of $2.98 billion, up 5% on both a reported and organic basis, and GAAP diluted EPS of $0.57 versus a loss of $0.09 a year earlier. Adjusted diluted EPS fell 16% to $0.58, and the company raised its full-year 2026 outlook, including adjusted EPS of $2.05 to $2.15. The board also declared a $0.01 quarterly dividend payable January 4, 2027.
Q3 sales of approximately $2.98 billion, up 5% reported and organic; U.S. sales up 3% reported, international up 7% reported
GAAP diluted EPS of $0.57 versus a loss of $0.09 a year earlier; adjusted diluted EPS of $0.58, down 16% from $0.69, due to a higher effective tax rate
Full-year 2026 adjusted EPS outlook raised to $2.05 to $2.15 from $1.95 to $2.15; reported sales growth raised to 4% to 5% from 3% to 4%
Quarterly dividend of $0.01 per share, record date November 27, 2026, payable January 4, 2027
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Baxter International's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$11.24B
+5.7%
$-1.87
—
-8.5%
FY2024
$10.64B
+2.7%
$-1.27
-124.3%
-6.1%
FY2023
$10.36B
+3.0%
$5.23
—
25.6%
FY2022
$10.06B
-17.2%
$-4.83
-290.9%
-24.2%
FY2021
$12.15B
+4.1%
$2.53
+18.8%
10.6%
Frequently asked questions
When is Baxter International's next earnings date?
Baxter International has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Baxter International earn last quarter?
For the quarter ended Sep 2026, Baxter International reported diluted EPS of $0.57 on revenue of $2.98B (+5.0%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.